Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy

Exclusion Criteria

• •• Acute or recurrent urinary tract infection (UTI), or genital infection (e.g. herpes candida).
• •* Prolapse staged ≥ II, according to the pelvic organ prolapse quantification (ICS-POP-Q) system
• •* Any serious disease, or chronic condition, that could interfere with the study compliance
• •* Previously undergone reconstructive pelvic surgery
• •* Have used vaginal creams, moisturizers, lubricants or homeopathic preparations for at least 3 months
• •* A history of thrombophlebitis
• •* A history of acute infections
• •* A history of heart failure
• •* Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics, vitamin E or anti inflammatories within 2 weeks pre treatment
• •* Any medical condition, that, in the investigator's opinion would interfere with the patient's participation in the study
• •* Taking medications that are photosensitive
• •* A history of keloid formation